Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-01-22 | Laurie H. Glimcher Independent Director since: 2020 Age: 69 Committee(s): Compensation Dr. Glimcher has served as a Professor of Microbiology and Immunology at Harvard Medical School since May 2017, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute since October 2016, an Attending Physician, Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute since October 2016 and the President and Chief Executive Officer of the Dana-Farber Cancer Institute since September 2016. In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1984 to 2011 and from October 2016 to present, she also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and as Provost for Medical Affairs of Cornell University from January 2012 to August 2016. She is a member of the Board of Trustees at the Dana-Farber Cancer Institute and a member of the US National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. Dr. Glimcher’s scientific and public health expertise as well as diversity of technical skills and experience as a physician, scientist and professor. Laurie H. Glimcher received total compensation of $139,145 in fiscal 2020. |
| 2022-01-21 | Laurie H. Glimcher Independent Director since: 2020 Age: 70 Committee(s): Compensation Professional Experience and Background Dr. Glimcher has served as a Professor of Microbiology and Immunology at Harvard Medical School since May 2017, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute since October 2016, an Attending Physician, Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute since October 2016 and the President and Chief Executive Officer of the Dana-Farber Cancer Institute since September 2016. In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1984 to 2011 and from October 2016 to present, she also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University from January 2012 to August 2016. She is a member of the Board of Trustees at the Dana-Farber Cancer Institute and a member of the US National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. Key Qualifications and Expertise Dr. Glimcher's scientific and public health expertise as well as diversity of technical skills and experience as a physician, scientist and professor. Other Public Company Boards: Current: GlaxoSmithKline plc Past 5 Years: Bristol-Myers Squibb Company (until 2017) Waters Corporation (until 2020) Fiscal 2021 Director Compensation Laurie H. Glimcher Fees Earned or Paid in Cash ($): 90,000 Stock Awards ($): 207,144 All Other Compensation ($): Total ($): 297,144 |
| 2023-01-20 | Professor of Medicine at Harvard Medical School. |
Data sourced from SEC filings. Last updated: 2025-07-01